Cite

HARVARD Citation

    Hompland, I. et al. (2016). Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour. Clinical sarcoma research. 6 (1), pp. 1-8. [Online]. 
  
Back to record